VYNE – vyne therapeutics inc. (US:NASDAQ)
Stock Stats
News
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
VYNE Therapeutics receives FDA approval for trial of VYN202 [Yahoo! Finance]
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Form 10-Q VYNE Therapeutics Inc. For: Mar 31
Form 8-K VYNE Therapeutics Inc. For: May 09
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Zeronda Tyler
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Stuart Iain
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Harsch Mutya
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.